Treatment Outcomes for Brain Metastasis From Primary RCC: A National Cancer Database Analysis

Manmeet Ahluwalia, MD, MBA, FASCO, of Miami Cancer Institute, highlights a US National Cancer Database analysis on treatment outcomes of brain metastasis from primary renal cell carcinoma.

Through this analysis, he and his colleagues were able to show that the combination of stereotactic radiosurgery with immunotherapy significantly increases the OS in RCCBM compared with immunotherapy, WBRT, or combination of WBRT and immunotherapy.